# Furosemide

Drug · id `cardio:furosemide` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

Also called: Lasix

Browse, organ or system: Heart; Kidneys  
Browse, condition area: High blood pressure; Heart failure; Kidney connections  

## In plain language

Furosemide, sold as Lasix, is a diuretic that works on the kidney, taken by mouth in the form read here. The US label read, for Lasix tablets, lists swelling from fluid build-up in people with congestive heart failure, cirrhosis of the liver and kidney disease including the nephrotic syndrome, in adults and children. It says the oral form may also be used in adults for high blood pressure, alone or with other blood pressure medicines.

## Technical summary

RxNorm ingredient 4603; UNII 7LXU5N7ZO5. MeSH descriptor D005665 is Furosemide. Class: Loop Diuretic (FDA established pharmacologic class, RxClass). The label read is the Validus Pharmaceuticals LLC label for Lasix tablets, application NDA016273, effective 2025-09-30 in openFDA; the cluster that wrote the loop diuretic class page read the same label. Other furosemide products in openFDA, including the injection labels and the Lasix ONYU subcutaneous product, were not read. This page records label indications, the mechanism sentence and the class only: no trial result and no dose is given.

## Claims, with the population each applies to

## Context: Adults and pediatric patients with edema, and adults with hypertension, as described in the US label of a loop diuretic

Recipient: Mixed recipients; Population: Patients described in the indications section of the label: adults and pediatric patients with edema associated with congestive heart failure, cirrhosis of the liver or renal disease, and adults with hypertension.; Care setting: Prescription medicine, as described in the US label; Geography: United States (US drug label); Life stage: Adults and pediatric patients for edema; adults for hypertension, as the label states; Gestational age: Not reported; Postnatal age: Not reported; Follow-up: Not applicable (label statement)

### The US label of Lasix (furosemide tablets, Validus Pharmaceuticals LLC, application NDA016273; the version dated 2025-09-30 in openFDA) lists the treatment of edema associated with congestive heart failure, cirrhosis of the liver and renal disease, including the nephrotic syndrome, in adults and pediatric patients. It says oral Lasix may be used in adults for the treatment of hypertension alone or in combination with other antihypertensive agents.

- Category: Description
- Evidence stage: Evidence stage not applicable
- Certainty: Certainty not assessed
- Applies to: Recipient: Mixed recipients; Population: Patients described in the indications section of the label: adults and pediatric patients with edema associated with congestive heart failure, cirrhosis of the liver or renal disease, and adults with hypertension.; Care setting: Prescription medicine, as described in the US label; Geography: United States (US drug label); Life stage: Adults and pediatric patients for edema; adults for hypertension, as the label states; Gestational age: Not reported; Postnatal age: Not reported; Follow-up: Not applicable (label statement)
- Limitations: This claim records what one US label says the medicine is indicated for. It is not a finding about how well the medicine works, and no trial result is recorded for it in this atlas. Other furosemide labels, including injections, list different routes and uses. Contraindications, warnings, interactions and dosing were not recorded. Labels change, and openFDA lists other versions with different dates. openFDA's own disclaimer says not to rely on it for decisions about medical care.
- Last checked: 2026-11-18
- Sources:
  1. Supports: openFDA drug label record for LASIX (furosemide tablets), Validus Pharmaceuticals LLC label: indications and class description (Regulator, edition The openFDA drug label record for set id 2c9b4d8f-0770-482d-a9e6-9c616a440b1a (manufacturer Validus Pharmaceuticals LLC, application NDA016273), returned on 2026-11-09. The label text is dated 2025-09-30 (effective\_time). Other openFDA records of labels for the same ingredient from other sponsors and repackagers exist and were not used.) <https://api.fda.gov/drug/label.json?search=set_id:%222c9b4d8f-0770-482d-a9e6-9c616a440b1a%22&limit=1>
     Locator: results\[0\].indications\_and\_usage\[0\], INDICATIONS AND USAGE, Edema. Retrieved 2026-11-09T13:17:37Z. Source state: Current. Version fingerprint: ed9855aad2ab51bda46903f2319af7d32d4fcf9954b059cd6afc33672d16a4f0.
     How it applies: Label passage quoted in the research quote table (LB-04, LB-05).
  2. Supports: openFDA drug label record for LASIX (furosemide tablets), Validus Pharmaceuticals LLC label: indications and class description (Regulator, edition The openFDA drug label record for set id 2c9b4d8f-0770-482d-a9e6-9c616a440b1a (manufacturer Validus Pharmaceuticals LLC, application NDA016273), returned on 2026-11-09. The label text is dated 2025-09-30 (effective\_time). Other openFDA records of labels for the same ingredient from other sponsors and repackagers exist and were not used.) <https://api.fda.gov/drug/label.json?search=set_id:%222c9b4d8f-0770-482d-a9e6-9c616a440b1a%22&limit=1>
     Locator: results\[0\].indications\_and\_usage\[0\], INDICATIONS AND USAGE, Hypertension. Retrieved 2026-11-09T13:17:37Z. Source state: Current. Version fingerprint: ed9855aad2ab51bda46903f2319af7d32d4fcf9954b059cd6afc33672d16a4f0.
     How it applies: Label passage quoted in the research quote table (LB-06).
  3. Background: openFDA drug label record for LASIX (furosemide tablets), Validus Pharmaceuticals LLC label: indications and class description (Regulator, edition The openFDA drug label record for set id 2c9b4d8f-0770-482d-a9e6-9c616a440b1a (manufacturer Validus Pharmaceuticals LLC, application NDA016273), returned on 2026-11-09. The label text is dated 2025-09-30 (effective\_time). Other openFDA records of labels for the same ingredient from other sponsors and repackagers exist and were not used.) <https://api.fda.gov/drug/label.json?search=set_id:%222c9b4d8f-0770-482d-a9e6-9c616a440b1a%22&limit=1>
     Locator: results\[0\].effective\_time. Retrieved 2026-11-09T13:17:37Z. Source state: Current. Version fingerprint: ed9855aad2ab51bda46903f2319af7d32d4fcf9954b059cd6afc33672d16a4f0.
     How it applies: Effective date of the label text read, 20250930.

## Connected pages

- Furosemide is a loop diuretic (FDA established pharmacologic class in RxClass): Loop diuretics (`cardio:loop-diuretics`)
- FDA label lists edema associated with congestive heart failure as an indication: Heart failure (`cardio:heart-failure`) [a claim, not a settled fact; see claim `cardio:claim-fda-furosemide-label-indications` and its context]
- FDA label says the oral form may be used for hypertension: Hypertension (high blood pressure) (`core:hypertension`) [a claim, not a settled fact; see claim `cardio:claim-fda-furosemide-label-indications` and its context]
- Files under this front: Medicines (`cardio:front-medicines`)

## Provenance

Content hash: 7f147c8cd6a0a72821f9a0bca0d97fbc555914baa702999a9da85a39351ab4cf
Last substantive edit: 2026-11-18
Evidence last checked: 2026-11-18
